未登录 分享 收藏
分享 收藏
分享 收藏
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials 拓宽入组途径：对胰腺癌和胆道癌临床试验中潜在可调整的入组标准的分析 Saj, Fen; Namayanja, Felicity K.; Xiao, Lianchun; Borad, Mitesh J.; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S.; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W.; Fashoyin-aje, Lola A.; Javle, Milind 分享 收藏
Pemigatinib for previously treated metastatic or unresectable central nervous system tumors with fibroblast growth factor receptor mutations or rearrangements: FIGHT-207 results 培米加替尼用于既往治疗过的具有成纤维细胞生长因子受体突变或重排的转移性或不可切除的中枢神经系统肿瘤：FIGHT-207研究结果 Spanggaard, Iben; Matrana, Marc; Rocha Lima, Caio; Mahipal, Amit; Vieito, Maria; Hervieu, Alice; Goyal, Lipika; Rodon, Jordi; Veronese, Maria Luisa; Oliveira, Natalia; Li, Xin; Schaffer, Michael; Kesari, Santosh 分享 收藏
分享 收藏
分享 收藏
Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study Li, Michael; Hannan, Lindsay M.; Goyal, Lipika; Bocobo, Andrea G.; Parks, Anna L.; Bauer, Kelly; Baiev, Islam; Dinicola, Caroline; Gordan, John D.; Venook, Alan P.; Harris, William P.; Bracci, Paige; Kelley, Robin K. 分享 收藏
分享 收藏
Lenvatinib (L) and sorafenib (S) in patients (pts) with advanced or unresectable hepatocellular carcinoma (uHCC): An international, multicenter, phase IV study (STELLAR) 伦伐替尼（L）和索拉非尼（S）在晚期或不可切除的肝细胞癌（uHCC）患者（pts）中的应用：一项国际、多中心、IV期研究（STELLAR）。 Radosavljevic, M. Peck; Abdelgafur, A. M.; Granito, A.; Gasbarrini, A.; Ma, Y.; Mena, E.; Lledo-Navarro, J. L.; Presa, J.; Weinmann, A.; Levy, M. T.; Pellicelli, A.; Waldschmidt, D. T.; Sorensen, H. T.; Goyal, L.; Ren, M.; Saal, H.; Okpara, C. E.; Meyer, T. 分享 收藏
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer FOENIX-CCA2研究的简明语言摘要: futibatinib用于晚期胆管癌患者 Goyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A. 分享 收藏
分享 收藏
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC Azad, Nilofer; Hu, Zishuo; Sahin, Ilyas; Iyer, Renuka; Aranha, Olivia; Hochster, Howard; Pathak, Priyadarshini; Paulson, Andrew Scott; Kalyan, Aparna; Liao, Chih-Yi; Tran, Nguyen; Kelley, Robin K.; Heestand, Gregory; Cosgrove, David; El-Khoueiry, Anthony; Borad, Mitesh; Gabrail, Nashat Y.; Majeed, Umair; Du, Lingling; Kamath, Suneel; Shumway, Nathan; Shroff, Rachna; Goyal, Lipika; Rosales, Minori; Javle, Milind 分享 收藏
分享 收藏
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial (May, 10.1038/s41591-024-02934-7, 2024) Rodon, Jordi; Damian, Silvia; Furqan, Muhammad; Garcia-Donas, Jesus; Imai, Hiroo; Italiano, Antoine; Spanggaard, Iben; Ueno, Makoto; Yokota, Tomoya; Veronese, Maria Luisa; Oliveira, Natalia; Li, Xin; Gilmartin, Aidan; Schaffer, Michael; Goyal, Lipika 分享 收藏
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial 通过FUZE多中心，开放标签，II期篮子试验评估FGFR融合阳性晚期实体瘤患者的Debio 1347 Grivas, Petros; Garralda, Elena; Meric-Bernstam, Funda; Mellinghoff, Ingo K.; Goyal, Lipika; Harding, James J.; Dees, E. Claire; Bahleda, Rastislav; Azad, Nilofer S.; Karippot, Asha; Kurzrock, Razelle; Tabernero, Josep; Kononen, Juha; Ng, Matthew C. H.; Mehta, Rutika; Uboha, Nataliya V.; Bigot, Frederic; Boni, Valentina; Bowyer, Samantha E.; Breder, Valeriy; Cervantes, Andres; Chan, Nancy; Cleary, James M.; Dhawan, Mallika; Eefsen, Rikke L.; Ewing, James; Graham, Donna M.; Guren, Tormod K.; Won Kim, Jin; Koynov, Krassimir; Oh, Do-Youn; Redman, Rebecca; Yen, Chia-Jui; Spetzler, David; Roubaudi-Fraschini, Marie-Claude; Nicolas-Metral, Valerie; Ait-Sarkouh, Rafik; Zanna, Claudio; Ennaji, Abdallah; Pokorska-Bocci, Anna; Flaherty, Keith T. 分享 收藏
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial Rodon, Jordi; Damian, Silvia; Furqan, Muhammad; Garcia-Donas, Jesus; Imai, Hiroo; Italiano, Antoine; Spanggaard, Iben; Ueno, Makoto; Yokota, Tomoya; Veronese, Maria Luisa; Oliveira, Natalia; Li, Xin; Gilmartin, Aidan; Schaffer, Michael; Goyal, Lipika 分享 收藏
Treatment of cholangiocarcinoma using humanized monoclonal antibodies targeting claudin-1 Nehme, Zeina; Muller, Marion; Crouchet, Emilie; Juehling, Frank; Moehlin, Julien; Desert, Romain; Brochon, Jade; Del Zompo, Fabio; Roehlen, Natascha; Thumann, Christine; Pessaux, Patrick; Felli, Emanuele; Venkatasamy, Aina; Marchand, Patrice; Onea, Mihaela Alina; Iacone, Roberto; Meyer, Markus; Toso, Alberto; Bardeesy, Nabeel; Goyal, Lipika; Ranvir, Vikas Prakash; Fernandez-Vaquero, Mirian; Heikenwalder, Mathias; Ostyn, Tessa; Roskams, Tania; Laquerriere, Patrice; Schuster, Catherine; Mailly, Laurent; Baumert, Thomas F. 分享 收藏
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients 不可逆FGFR1-4抑制剂Futibatinib的安全性和不良事件管理: 469例患者的汇总安全性分析 Meric-Bernstam, Funda; Hollebecque, Antoine; Furuse, Junji; Oh, Do-Youn; Bridgewater, John A.; Shimura, Masashi; Anderson, Bailey; Hangai, Nanae; Wacheck, Volker; Goyal, Lipika 分享 收藏
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors Yoo, Changhoon; Lamarca, Angela; Choi, Hye Jin; Vogel, Arndt; Pishvaian, Michael J.; Goyal, Lipika; Ueno, Makoto; Maerten, Angela; Teufel, Michael; Geng, Lijiang; Morizane, Chigusa 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
